GT Biopharma (GTBP) Prepaid Assets (2016 - 2021)
GT Biopharma (GTBP) has disclosed Prepaid Assets for 10 consecutive years, with $85000.0 as the latest value for Q3 2021.
- On a quarterly basis, Prepaid Assets fell 82.4% to $85000.0 in Q3 2021 year-over-year; TTM through Sep 2021 was $85000.0, a 82.4% decrease, with the full-year FY2020 number at $364000.0, up 47.97% from a year prior.
- Prepaid Assets was $85000.0 for Q3 2021 at GT Biopharma, up from $62000.0 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $483000.0 in Q3 2020 to a low of $15000.0 in Q3 2018.
- A 4-year average of $143250.0 and a median of $86500.0 in 2021 define the central range for Prepaid Assets.
- Peak YoY movement for Prepaid Assets: soared 1912.5% in 2020, then tumbled 82.4% in 2021.
- GT Biopharma's Prepaid Assets stood at $15000.0 in 2018, then surged by 1540.0% to $246000.0 in 2019, then surged by 47.97% to $364000.0 in 2020, then tumbled by 76.65% to $85000.0 in 2021.
- Per Business Quant, the three most recent readings for GTBP's Prepaid Assets are $85000.0 (Q3 2021), $62000.0 (Q2 2021), and $88000.0 (Q1 2021).